LivaNova

AI Score

0
XX

Unlock

47.58
0.26 (0.55%)
At close: Jan 14, 2025, 3:59 PM
48.65
2.25%
Pre-market Jan 15, 2025, 07:33 AM EST

LivaNova Revenue Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020
Cardiopulmonary Segment Revenue 172.24M 173.71M 155.89M 161.47M 144.83M 150.60M 132.07M 136.46M 120.96M 125.82M 117.08M 121.55M 113.29M 117.64M 103.70M 109.17M 98.41M 57.21M 89.66M
Cardiopulmonary Segment Revenue Growth -0.85% +11.43% -3.46% +11.50% -3.84% +14.03% -3.22% +12.82% -3.86% +7.47% -3.68% +7.29% -3.70% +13.44% -5.01% +10.93% +72.01% -36.19% n/a
Neuromodulation Segment Revenue 139.86M 142.88M 133.87M 136.93M 128.88M 133.18M 120.72M 127.14M 121.83M 117.80M 110.23M n/a n/a n/a n/a n/a n/a n/a n/a
Neuromodulation Segment Revenue Growth -2.11% +6.73% -2.23% +6.24% -3.23% +10.32% -5.04% +4.35% +3.43% +6.87% n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2017Dec 31, 2016
Europe Revenue 214.79M 178.80M 201.53M 193.37M 223.18M 210.47M 402.07M
Europe Revenue Growth +20.13% -11.28% +4.22% -13.36% +6.04% -47.65% n/a
Locations Excluding The United States And Europe Revenue 303.71M 271.44M 262.54M 272.24M 546.48M 494.72M 490.51M
Locations Excluding The United States And Europe Revenue Growth +11.89% +3.39% -3.56% -50.18% +10.46% +0.86% n/a
United States Revenue 635.04M 571.56M 571.30M 468.63M n/a n/a n/a
United States Revenue Growth +11.11% +0.05% +21.91% n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Oct 18, 2015Sep 30, 2015Apr 30, 2015Jan 31, 2015
Selling, General, and Administrative Revenue 131.66M 129.12M 129.86M 133.30M 134.80M 125.90M 124.10M 119.60M 114.63M 116.50M 118.53M 124.40M 109.04M 122.75M 112.62M 110.30M 99.20M 98.05M 120.20M 130.60M 123.02M 127.21M 125.70M 122.20M 115.14M 123.40M 104.20M 101.60M 121.18M 120.37M 112.40M 123.50M 107.55M 120.20M 115.60M 41.19M 33.71M 30.41M 31.33M
Selling, General, and Administrative Revenue Growth +1.97% -0.57% -2.58% -1.11% +7.07% +1.45% +3.76% +4.34% -1.61% -1.71% -4.72% +14.08% -11.17% +9.00% +2.10% +11.19% +1.17% -18.43% -7.96% +6.17% -3.30% +1.20% +2.87% +6.14% -6.70% +18.43% +2.56% -16.16% +0.67% +7.09% -8.99% +14.83% -10.52% +3.98% +180.68% +22.19% +10.82% -2.92% n/a
Research and Development Revenue 48.80M 44.74M 41.86M 46.20M 46.50M 51.10M 50.00M 44.90M 35.73M 34.20M 40.92M 44.10M 42.13M 52.56M 44.63M 44.50M 47.37M 25.15M 35.90M 25.90M 45.90M 34.54M 43.58M 37.60M 42.42M 34.20M 31.80M 32.50M 31.39M 43.01M 29.65M 28.40M 32.17M 30.20M 31.70M 15.25M 10.06M 11.37M 10.53M
Research and Development Revenue Growth +9.09% +6.86% -9.39% -0.65% -9.00% +2.20% +11.36% +25.68% +4.46% -16.42% -7.22% +4.67% -19.83% +17.77% +0.28% -6.05% +88.33% -29.94% +38.61% -43.58% +32.89% -20.73% +15.89% -11.36% +24.03% +7.55% -2.15% +3.53% -27.00% +45.04% +4.40% -11.73% +6.54% -4.73% +107.88% +51.56% -11.55% +8.02% n/a

Create Price Alert on LIVN

Your price alert will notify you when the stock price is above 47.58.

Add to Watchlist